Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.
The 2024 report on China’s gastroenterology and digestive endoscopy, based on national databases, highlights increased early cancer detection, optimized care for priority diseases, and enhanced ...
When CMS quietly updated the Medically Unlikely Edit (MUE) for CPT 64772 from two to six units for 2026, it didn’t make headlines, but it should have. This change isn’t simply a coding adjustment. It ...
Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.
Boston Scientific BSX has a stretched valuation, reflected in its Value Score of C. Shares of the company are trading at a ...
A video of a fight between patient Arjun Panwar and a doctor at Indira Gandhi Medical College in Shimla has spread widely ...
Hong Kong’s inaugural Summit reveals how the scientific community has successfully pioneered the adoption of revolutionary ...
Galectin Therapeutics remains committed to advancing belapectin’s development for patients with advanced fibrotic liver disease and continues to engage constructively with the FDA as it progresses the ...
Chronic vomiting in cats isn’t normal. Learn the common causes—from hairballs and food sensitivities to IBD and metabolic disease.
XP Power explores the trends that will continue to drive medical technology in 2026 and how they will influence ...
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback